Clarity Pharmaceuticals (Clarity Pharmaceuticals) Total Liabilities : $3.42 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Clarity Pharmaceuticals Total Liabilities?

Clarity Pharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2023 was $3.42 Mil.

Clarity Pharmaceuticals's quarterly Total Liabilities declined from Dec. 2022 ($5.34 Mil) to Jun. 2023 ($5.18 Mil) and declined from Jun. 2023 ($5.18 Mil) to Dec. 2023 ($3.42 Mil).

Clarity Pharmaceuticals's annual Total Liabilities increased from . 20 ($0.00 Mil) to Jun. 2022 ($5.33 Mil) but then declined from Jun. 2022 ($5.33 Mil) to Jun. 2023 ($5.18 Mil).

Clarity Pharmaceuticals Total Liabilities Historical Data

The historical data trend for Clarity Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Total Liabilities Chart

Clarity Pharmaceuticals Annual Data

Trend

Jun22

Jun23

Total Liabilities

5.33

5.18

Clarity Pharmaceuticals Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial			1.87	5.33	5.34	5.18	3.42

Clarity Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Clarity Pharmaceuticals's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.062	+	(0	+	1.1102230246252E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.12)
	=	5.18

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	51.608	-	46.427
	=	5.18

Clarity Pharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.276	+	(0	+	0.146
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.42

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	38.937	-	35.515
	=	3.42

Clarity Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarity Pharmaceuticals (Clarity Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (OTCPK:CLRPF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CU6:Australia

Address

4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015

Website

https://www.claritypharmaceuticals.com

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.